Brave Asset Management Inc. trimmed its stake in MetLife, Inc. (NYSE:MET) by 4.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 60,602 shares of the financial services provider’s stock after selling 2,803 shares during the quarter. MetLife makes up 1.7% of Brave Asset Management Inc.’s portfolio, making the stock its 14th biggest holding. Brave Asset Management Inc.’s holdings in MetLife were worth $3,148,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ballentine Partners LLC purchased a new stake in shares of MetLife in the first quarter valued at $265,000. Skandinaviska Enskilda Banken AB publ grew its position in shares of MetLife by 0.3% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 156,115 shares of the financial services provider’s stock valued at $8,246,000 after purchasing an additional 502 shares during the period. Sowell Financial Services LLC grew its position in shares of MetLife by 8.5% in the first quarter. Sowell Financial Services LLC now owns 10,634 shares of the financial services provider’s stock valued at $537,000 after purchasing an additional 829 shares during the period. Aviance Capital Management LLC grew its position in shares of MetLife by 4.6% in the first quarter. Aviance Capital Management LLC now owns 9,389 shares of the financial services provider’s stock valued at $496,000 after purchasing an additional 416 shares during the period. Finally, Aldebaran Financial Inc. grew its position in shares of MetLife by 1.2% in the first quarter. Aldebaran Financial Inc. now owns 34,321 shares of the financial services provider’s stock valued at $1,813,000 after purchasing an additional 400 shares during the period. 76.37% of the stock is owned by institutional investors.

A number of brokerages have recently commented on MET. Langen Mcalenn reaffirmed a “buy” rating on shares of MetLife in a research report on Wednesday, August 16th. ValuEngine raised MetLife from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 11th. Zacks Investment Research downgraded MetLife from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. BidaskClub raised MetLife from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Finally, Argus lowered their price target on MetLife from $60.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, August 9th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. MetLife presently has an average rating of “Buy” and an average target price of $58.40.

In other MetLife news, insider Christopher G. Townsend sold 55,712 shares of the business’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now owns 25,181 shares in the company, valued at $1,367,076.49. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Christopher G. Townsend sold 82,731 shares of the business’s stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $54.60, for a total value of $4,517,112.60. Following the transaction, the insider now owns 49,660 shares in the company, valued at approximately $2,711,436. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

Shares of MetLife, Inc. (MET) traded up $0.01 on Tuesday, hitting $53.62. The company’s stock had a trading volume of 4,118,600 shares, compared to its average volume of 5,744,903. The firm has a market capitalization of $56,360.00, a PE ratio of 10.31, a PEG ratio of 1.35 and a beta of 1.49. MetLife, Inc. has a 12 month low of $44.26 and a 12 month high of $55.91. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.19. The company had revenue of $16.10 billion for the quarter, compared to analysts’ expectations of $15.47 billion. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.28 earnings per share. analysts predict that MetLife, Inc. will post 4.43 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 13th. Shareholders of record on Monday, November 6th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.98%. The ex-dividend date is Friday, November 3rd. MetLife’s dividend payout ratio is presently 347.83%.

ILLEGAL ACTIVITY WARNING: This news story was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://theolympiareport.com/2017/12/05/brave-asset-management-inc-has-3-15-million-stake-in-metlife-inc-met.html.

MetLife Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.